The Lancet Regional Health Europe
Long-term adherence to glucose-lowering therapy and cardiovascular risk in type 2 diabetes: a nationwide cohort study
Study in peoplePopulations
The paper
University of Copenhagen
The Lancet Regional Health Europe, 31 Jul 2026

